No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
VYNE VYNE Therapeutics
- 2.5000
- +0.1100+4.60%
Close Dec 20 16:00 ET
- 2.5000
- 0.00000.00%
Post 20:01 ET
36.88MMarket Cap0.74P/E (TTM)
2.5500High2.3600Low34.73KVolume2.3600Open2.3900Pre Close85.83KTurnover0.34%Turnover RatioLossP/E (Static)14.75MShares3.430052wk High0.58P/B25.86MFloat Cap1.570052wk Low--Dividend TTM10.34MShs Float2869.9200Historical High--Div YieldTTM7.95%Amplitude1.5700Historical Low2.4710Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
VYNE Therapeutics Sees Strong Shareholder Support for Growth
VYNE Therapeutics Initiated With a Buy at BTIG on I&I Potential
VYNE Therapeutics Analyst Ratings
Express News | Vyne Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Price Target $8
TD Cowen Maintains VYNE Therapeutics(VYNE.US) With Buy Rating, Maintains Target Price $5
VYNE Therapeutics | 10-Q: Q3 2024 Earnings Report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List